Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2014

Open Access 01-12-2014 | Study protocol

Detecting the neuropathic pain component in the clinical setting: a study protocol for validation of screening instruments for the presence of a neuropathic pain component

Authors: Hans Timmerman, Oliver Wilder-Smith, Chris van Weel, André Wolff, Kris Vissers

Published in: BMC Neurology | Issue 1/2014

Login to get access

Abstract

Background

The presence of nerve damage plays a key role in the development and prognosis of chronic pain states. Assessment of the presence and severity of a neuropathic pain component (NePC) is key in diagnosing chronic pain patients. Low back pain (LBP) and neck and shoulder pain (NSP) are highly prevalent and clinically important medical and societal problems in which a NePC is frequently present. The more severe the NePC, the worse the course of the pain, its prognosis and the results of treatment. Reliable and standardised diagnosis of the NePC remains difficult to achieve. Standardized and validated screening tools may help to reliably identify the NePC in individual chronic pain patients. The aim of this study is to validate the Dutch language versions of the PainDETECT Questionnaire (PDQ-Dlv) and the ‘Douleur Neuropathique 4 Questions’ (DN4-Dlv) for use in primary and specialist medical care settings to screen for a NePC in patients with chronic pain due to (1) LBP, (2) NSP or (3) known peripheral nerve damage (PND).

Methods/design

The study design is cross-sectional to assess the validity of the PDQ-Dlv and the DN4-Dlv with 2 weeks follow-up for test-retest reliability and 3 months follow-up for monitoring and prognosis. 438 patients with chronic pain due to (1) LBP, (2) NSP or (3) PND. will be included in this study. Based on the IASP definition of neuropathic pain, two physicians will independently assess whether the patient has a NEPC or not. This result will be compared with the outcome of the PDQ-Dlv & DN4-Dlv, the grading system for neuropathic pain, bed side examination and quantitative sensory testing. This study will further collect data regarding prevalence of NePC, general health status, mental health status, functioning, pain attribution and quality of life.

Discussion

The rationale for this study is to provide detailed information on the clinimetric quality of the PDQ-Dlv and DN4-Dlv in Dutch speaking countries. Our innovative multi-factorial approach should help achieve more reliable diagnosis and quantification of a NePC in patients with chronic pain.

Trial registration

The Netherlands National Trial Register (NTR3030).
Appendix
Available only for authorised users
Literature
1.
Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J: Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008, 70 (18): 1630-1635. 10.1212/01.wnl.0000282763.29778.59.CrossRefPubMed
2.
Freynhagen R, Baron R, Gockel U, Tolle TR: painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006, 22 (10): 1911-1920. 10.1185/030079906X132488.CrossRefPubMed
3.
Freynhagen R, Baron R: The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009, 13 (3): 185-190. 10.1007/s11916-009-0032-y.CrossRefPubMed
4.
Pinto RZ, Maher CG, Ferreira ML, Ferreira PH, Hancock M, Oliveira VC, McLachlan AJ, Koes B: Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis. BMJ. 2012, 344: e497-10.1136/bmj.e497.CrossRefPubMedPubMedCentral
5.
Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, Nurmikko T: European Federation of Neurological S: EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010, 17 (9): 1113-e1188. 10.1111/j.1468-1331.2010.02999.x.CrossRefPubMed
6.
Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC: Incidence rates and treatment of neuropathic pain conditions in the general population. Pain. 2008, 137 (3): 681-688. 10.1016/j.pain.2008.03.002.CrossRefPubMed
7.
Schers H, Bor H, van den Hoogen H, van Weel C: What went and what came? Morbidity trends in general practice from the Netherlands. Eur J Gen Pract. 2008, 14 (Suppl 1): 13-24.CrossRefPubMed
8.
Van Den Linden MWWGP, De Bakker DH, Schellevis FG: Tweede nationale studie naar ziekten en verrichtingen in de huisartsenpraktijk: klachten een aandoeningen in de bevolking en in de huisartspraktijk. 2004, Utrecht/Bilthoven: NIVEL/RIVM
9.
Vissers KC: The clinical challenge of chronic neuropathic pain. Disabil Rehabil. 2006, 28 (6): 343-349. 10.1080/09638280500287270.CrossRefPubMed
10.
Baron R, Binder A, Wasner G: Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010, 9 (8): 807-819. 10.1016/S1474-4422(10)70143-5.CrossRefPubMed
11.
Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, Haanpaa M, Jensen TS, Serra J, Treede RD: EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010, 17 (8): 1010-1018. 10.1111/j.1468-1331.2010.02969.x.CrossRefPubMed
12.
Haanpaa M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA, Iannetti GD, Jensen TS, Kauppila T, Nurmikko TJ, Rice AS, Rowbotham M, Serra J, Sommer C, Smith BH, Treede RD: NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011, 152 (1): 14-27. 10.1016/j.pain.2010.07.031.CrossRefPubMed
13.
Bennett MI, Attal N, Backonja MM, Baron R, Bouhassira D, Freynhagen R, Scholz J, Tolle TR, Wittchen HU, Jensen TS: Using screening tools to identify neuropathic pain. Pain. 2007, 127 (3): 199-203. 10.1016/j.pain.2006.10.034.CrossRefPubMed
14.
Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lantéri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E: Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005, 114 (1–2): 29-36.CrossRefPubMed
15.
Van Seventer R, Vos C, Meerding W, Mear I, Le Gal M, Bouhassira D, Huygen FJ: Linguistic validation of the DN4 for use in international studies. Eur J Pain. 2010, 14 (1): 58-63. 10.1016/j.ejpain.2009.01.005.CrossRefPubMed
16.
Timmerman H, Wolff AP, Schreyer T, Outermans J, Evers AW, Freynhagen R, Wilder Smith OH, Van Zundert J, Vissers KC: Cross-Cultural Adaptation to the Dutch Language of the PainDETECT-Questionnaire. Pain Pract. 2013, 13 (3): 206-214. 10.1111/j.1533-2500.2012.00577.x.CrossRefPubMed
17.
Haanpaa ML, Backonja MM, Bennett MI, Bouhassira D, Cruccu G, Hansson PT, Jensen TS, Kauppila T, Rice AS, Smith BH, Treede RD, Baron R: Assessment of neuropathic pain in primary care. Am J Med. 2009, 122 (10 Suppl): S13-S21.CrossRefPubMed
18.
19.
Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B: Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006, 123 (3): 231-243. 10.1016/j.pain.2006.01.041.CrossRefPubMed
20.
Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD: Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain. 2006, 10 (1): 77-88. 10.1016/j.ejpain.2005.02.003.CrossRefPubMed
21.
Krumova EK, Geber C, Westermann A, Maier C: Neuropathic pain: is quantitative sensory testing helpful?. Curr Diabetes Reports. 2012, 12 (4): 393-402. 10.1007/s11892-012-0282-7.CrossRef
22.
Wilder Smith OH: A Paradigm-Shift in Pain Medicine: Implementing a Systematic Approach to Altered Pain Processing in Everyday Clinical Practice Based on Quantitative Sensory Testing. 2013, Aalborg, Denmark: Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Aalborg UniversityCrossRef
23.
Yarnitsky D: Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010, 23 (5): 611-615. 10.1097/ACO.0b013e32833c348b.CrossRefPubMed
24.
Pud D, Granovsky Y, Yarnitsky D: The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain. 2009, 144 (1–2): 16-19.CrossRefPubMed
25.
Yarnitsky D, Arendt-Nielsen L, Bouhassira D, Edwards RR, Fillingim RB, Granot M, Hansson P, Lautenbacher S, Marchand S, Wilder-Smith O: Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain. 2010, 14 (4): 339-10.1016/j.ejpain.2010.02.004.CrossRefPubMed
26.
Salen BA, Spangfort EV, Nygren AL, Nordemar R: The disability rating index: an instrument for the assessment of disability in clinical settings. J Clin Epidemiol. 1994, 47 (12): 1423-1435. 10.1016/0895-4356(94)90086-8.CrossRefPubMed
27.
Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67 (6): 361-370. 10.1111/j.1600-0447.1983.tb09716.x.CrossRefPubMed
28.
Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997, 27 (2): 363-370. 10.1017/S0033291796004382.CrossRefPubMed
29.
Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002, 52 (2): 69-77. 10.1016/S0022-3999(01)00296-3.CrossRefPubMed
30.
Hays RD, Sherbourne CD, Mazel RM: The RAND 36-Item Health Survey 1.0. Health Econ. 1993, 2 (3): 217-227. 10.1002/hec.4730020305.CrossRefPubMed
31.
VanderZee KI, Sanderman R, Heyink J: A comparison of two multidimensional measures of health status: the Nottingham Health Profile and the RAND 36-Item Health Survey 1.0. Qual Life Res. 1996, 5 (1): 165-174. 10.1007/BF00435982.CrossRefPubMed
32.
VanderZee KI, Sanderman R, Heyink JW, De Haes H: Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status. Int J Behav Med. 1996, 3 (2): 104-122. 10.1207/s15327558ijbm0302_2.CrossRefPubMed
33.
Collins SL, Edwards J, Moore RA, Smith LA, McQuay HJ: Seeking a simple measure of analgesia for mega-trials: is a single global assessment good enough?. Pain. 2001, 91 (1–2): 189-194.CrossRefPubMed
34.
Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM: Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001, 94 (2): 149-158. 10.1016/S0304-3959(01)00349-9.CrossRefPubMed
35.
Fischer D, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H: Capturing the patient's view of change as a clinical outcome measure. JAMA. 1999, 282 (12): 1157-1162. 10.1001/jama.282.12.1157.CrossRefPubMed
36.
Flahault A, Cadilhac M, Thomas G: Sample size calculation should be performed for design accuracy in diagnostic test studies. J Clin Epidemiol. 2005, 58 (8): 859-862. 10.1016/j.jclinepi.2004.12.009.CrossRefPubMed
Metadata
Title
Detecting the neuropathic pain component in the clinical setting: a study protocol for validation of screening instruments for the presence of a neuropathic pain component
Authors
Hans Timmerman
Oliver Wilder-Smith
Chris van Weel
André Wolff
Kris Vissers
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2014
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-14-94

Other articles of this Issue 1/2014

BMC Neurology 1/2014 Go to the issue

Research article

Evaluation of subcortical grey matter abnormalities in patients with MRI-negative cortical epilepsy determined through structural and tensor magnetic resonance imaging

Study protocol

Long term cerebral and vascular complications after irradiation of the neck in head and neck cancer patients: a prospective cohort study: study rationale and protocol

Research article

Mindfulness based interventions in multiple sclerosis - a systematic review

Research article

Neuropsychological outcome after carbon monoxide exposure following a storm: a case-control study

Study protocol

GAME (Goals - Activity - Motor Enrichment): protocol of a single blind randomised controlled trial of motor training, parent education and environmental enrichment for infants at high risk of cerebral palsy

Study protocol

The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results